The interim analysis of ORIENT-11, a phase III double-blind randomized trial has shown a nearly two-fold increase in progression-free survival with addition of sintilimab to chemotherapy in patients with advanced or metastatic non-squamous non-small-cell lung cancer without EGFR or ALK genomic aberrations, according to research data presented at the International Association for the Study of Lung Cancer Virtual Presidential Symposium, eurekalert.org reported.
Scientists at The Wistar Institute may have discovered a new way of identifying and targeting hidden HIV viral reservoirs during treatment with antiretroviral therapy (ART). These findings were published in Cell Reports and may have translational implications for improving the long-term care of HIV positive people.
India's Prime Minister Narendra Modi has pledged to ramp up testing to one million per day over the next few weeks to tackle one of the world's worst outbreaks of the coronavirus. But can he achieve this, and are the tests being used reliable?